On the stock market since 1987, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
An average decline of 14% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades 31% below its peak. The market has trimmed its expectations for the company.
Sales run at $5.6M a year. A small number, but proof the product has real buyers.
It pays out $0.27 per share each year — regular cash for whoever holds the stock.
A loss of $18K against $5.6M in annual sales. And on top of that, sales fell from the year before.
On our five-subject report card, CMU sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: CMU is a high-risk stock — not yet profitable, and its future rides on its product catching on.